본문으로 건너뛰기
← 뒤로

Comparative Outcomes of No-Touch Radiofrequency Ablation Versus Tumor-Puncture Microwave Ablation for Small Hepatocellular Carcinoma.

Korean journal of radiology 2026 Vol.27(1) p. 34-47

Kim JH, Park SJ, Chung DJ, Hong HP, Lee JK, Yoon CJ, Lee JM

📝 환자 설명용 한 줄

[OBJECTIVE] This study aimed to compare the therapeutic outcomes of no-touch (NT) radiofrequency ablation (RFA) vs.

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • 표본수 (n) 144

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Kim JH, Park SJ, et al. (2026). Comparative Outcomes of No-Touch Radiofrequency Ablation Versus Tumor-Puncture Microwave Ablation for Small Hepatocellular Carcinoma.. Korean journal of radiology, 27(1), 34-47. https://doi.org/10.3348/kjr.2025.1108
MLA Kim JH, et al.. "Comparative Outcomes of No-Touch Radiofrequency Ablation Versus Tumor-Puncture Microwave Ablation for Small Hepatocellular Carcinoma.." Korean journal of radiology, vol. 27, no. 1, 2026, pp. 34-47.
PMID 41494675

Abstract

[OBJECTIVE] This study aimed to compare the therapeutic outcomes of no-touch (NT) radiofrequency ablation (RFA) vs. tumor-puncture microwave ablation (MWA) in the treatment of single hepatocellular carcinomas (HCCs) measuring ≤3 cm.

[MATERIALS AND METHODS] This multicenter retrospective study included 304 patients who underwent either NT-RFA (n = 144) or MWA (n = 160) for a single HCC measuring ≤3 cm. Comparative analyses were conducted for the overall cohort, while 81 patients per group were matched using propensity score matching (PSM). The analyzed outcomes included technical success, primary technique efficacy, local tumor progression (LTP), and major complications. Cumulative LTP was estimated using Kaplan-Meier analysis and compared using the log-rank text, while the rate of ablative margin ≥5 mm and ablation time were compared using Chi-squared and Mann-Whitney U tests, respectively.

[RESULTS] Technical success was achieved in 98.6% (142/144) and 100% (160/160) of in the NT-RFA and MWA patients, respectively before PSM ( = 0.224), and 98.8% (80/81) and 100% (81/81) after PSM ( = 1.000). The primary technique efficacies were 98.6% (142/144) and 100% (160/160) before PSM ( = 0.224), and 97.5 % (79/81) and 100% (81/81) after PSM ( = 0.497), respectively. The 1-, 2-, and 3-year cumulative LTP rates were 1.4%, 1.4%, and 2.3%, respectively, for NT-RFA and 5.1%, 8.6%, and 8.6%, respectively, for MWA before PSM ( = 0.013). After PSM, the corresponding rates were 0%, 0%, and 0% for NT-RFA, and 7.6%, 10.4%, and 10.4% for MWA ( = 0.006). Major complications were not observed. NT-RFA achieved a higher proportion, with an ablative margin ≥5 mm (88.7% [126/142] vs. 71.9% [115/160]; < 0.001), but required longer ablation times (median, 10.0 vs. 6.0 min; < 0.001).

[CONCLUSION] NT-RFA showed superior local tumor control compared to MWA, despite greater procedural complexity and longer ablation times.

MeSH Terms

Humans; Carcinoma, Hepatocellular; Liver Neoplasms; Female; Male; Retrospective Studies; Microwaves; Middle Aged; Treatment Outcome; Radiofrequency Ablation; Aged; Propensity Score; Adult

같은 제1저자의 인용 많은 논문 (5)